In a regulatory filing, Vera Therapeutics disclosed that its director Beth Seidenberg bought 311K shares of common stock on February 6th in a total transaction size of $2.2M. Shares of Vera Therapeutics are up 4.3% afterhours at $7.59.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VERA:
- Vera Therapeutics director Enright buys $12.0M in common stock
- Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
- Three new option listings and one option delisting on February 2nd
- Vera Therapeutics 14.286M share Spot Secondary priced at $7.00
- Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock